Cargando…

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)

INTRODUCTION: HDAC isoform-specific inhibitors may improve the therapeutic window while limiting toxicities. Developing inhibitors against class I isoforms poses difficulties as they share high homology among their catalytic sites; however, HDAC8 is structurally unique compared to other class I isof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez, Gonzalo, Bill, Kate Lynn J., Bid, Hemant Kumar, Braggio, Danielle, Constantino, Dylan, Prudner, Bethany, Zewdu, Abeba, Batte, Kara, Lev, Dina, Pollock, Raphael E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511720/ https://www.ncbi.nlm.nih.gov/pubmed/26200462 http://dx.doi.org/10.1371/journal.pone.0133302

Ejemplares similares

Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates
por: Lopez, Gonzalo, et al.
Publicado: (2017)

Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis
por: Zewdu, A, et al.
Publicado: (2016)

β-catenin S45F mutation results in apoptotic resistance
por: Braggio, Danielle, et al.
Publicado: (2020)

miR-133a function in the pathogenesis of dedifferentiated liposarcoma
por: Yu, Peter Y., et al.
Publicado: (2018)

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors
por: Braggio, Danielle Almeida, et al.
Publicado: (2022)

Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Alaggio, Rita, et al.
Publicado: (2013)

Plexiform malignant peripheral nerve sheath tumor(MPNST) in infancy and childhood--a case report.
por: Nam, E. S., et al.
Publicado: (1994)

Malignant peripheral nerve sheath tumors (MPNST) – Clinicopathological study and treatment outcome of twenty-four cases
por: Kar, Madhabananda, et al.
Publicado: (2006)

Metastatic Malignant Peripheral Nerve Sheath Tumor (MPNST) in Neurofibromatosis Type 1: Challenges in Diagnosis and Management
por: Pulliam, Steven, et al.
Publicado: (2022)

Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives
por: Prudner, Bethany C, et al.
Publicado: (2019)

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2023)

BCRP expression in schwannoma, plexiform neurofibroma and MPNST
por: de Vries, Maurits, et al.
Publicado: (2017)

MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro
por: Fischer-Huchzermeyer, Susan, et al.
Publicado: (2017)

Epithelioid Malignant Peripheral Nerve Sheath Tumor (Epithelioid-MPNST) Presenting as Bleeding Rectal Polyp: A Case Report with Systematic Literature Review
por: Patra, Susama, et al.
Publicado: (2019)

How Effective Are Noninvasive Tests for Diagnosing Malignant Peripheral Nerve Sheath Tumors in Patients with Neurofibromatosis Type 1? Diagnosing MPNST in NF1 Patients
por: Schwabe, Maria, et al.
Publicado: (2019)

Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST
por: Stratton, Jo Anne, et al.
Publicado: (2018)

Chromosome 8 gain is associated with high-grade transformation in MPNST
por: Dehner, Carina, et al.
Publicado: (2021)

Malignant transformation of plexiform neurofibroma to MPNST while on MEK inhibitor
por: Fasih, Samir, et al.
Publicado: (2021)

PRC2 loss drives MPNST metastasis and matrix remodeling
por: Brockman, Qierra R., et al.
Publicado: (2022)

SHH PATHWAY ACTIVATION IN DEDIFFERENTIATION DURING TUMOR PROGRESSION IN MPNST
por: Yakubov, R Y, et al.
Publicado: (2023)

Unmasking Intra-Tumoral Heterogeneity and Clonal Evolution in NF1-MPNST
por: Moon, Chang-In, et al.
Publicado: (2020)

Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
por: Keng, Vincent W., et al.
Publicado: (2012)

Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis
por: Melean, German, et al.
Publicado: (2010)

CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin
por: Kendall, Jed J., et al.
Publicado: (2016)

Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST
por: Lu, Hsiang-Chih, et al.
Publicado: (2018)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo
por: Kohlmeyer, Jordan L, et al.
Publicado: (2022)

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
por: Widemann, Brigitte C., et al.
Publicado: (2019)

Targeting the notch pathway: A potential therapeutic approach for desmoid tumors
por: Shang, Hui, et al.
Publicado: (2015)

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study
por: Szymanski, Jeffrey J., et al.
Publicado: (2021)

Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future
por: Reilly, Karlyne M., et al.
Publicado: (2017)

Correction: Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST
por: Lu, Hsiang-Chih, et al.
Publicado: (2021)

Link between p53 isoforms and angiogenesis: Current prospects
por: Bid, Hemant Kumar
Publicado: (2013)

Cross‐flow microfiltration for isolation, selective capture and release of liposarcoma extracellular vesicles
por: Casadei, Lucia, et al.
Publicado: (2021)

Plexiform neurofibroma of the liver, with malignant transformation to MPNST, in a pediatric patient without neurofibromatosis type 1
por: Ioannou, Maria, et al.
Publicado: (2023)

A call for curricular reform: Recognising the importance of race‐based medical education
por: Inshaar, Hafza, et al.
Publicado: (2022)

Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts
por: Fischer-Huchzermeyer, Susan, et al.
Publicado: (2018)

Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST
por: Heitkötter, Birthe, et al.
Publicado: (2016)

R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells
por: Weber, Shannon M., et al.
Publicado: (2021)

Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy
por: Wu, Lai Man Natalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nt7541thvr4r8tfukvmr089t7l